Literature DB >> 35466714

Replacing Needle Injection by a Novel Waterjet Technology Grants Improved Muscle Cell Delivery in Target Tissues.

Ruizhi Geng1, Jasmin Knoll1, Niklas Harland2, Bastian Amend2, Markus D Enderle3, Walter Linzenbold3, Tanja Abruzzese1, Claudia Kalbe4, Elisabeth Kemter5,6, Eckhard Wolf5,6, Martin Schenk7, Arnulf Stenzl2, Wilhelm K Aicher1.   

Abstract

Current regimen to treat patients suffering from stress urinary incontinence often seems not to yield satisfactory improvement or may come with severe side effects. To overcome these hurdles, preclinical studies and clinical feasibility studies explored the potential of cell therapies successfully and raised high hopes for better outcome. However, other studies were rather disappointing. We therefore developed a novel cell injection technology to deliver viable cells in the urethral sphincter complex by waterjet instead of using injection needles. We hypothesized that the risk of tissue injury and loss of cells could be reduced by a needle-free injection technology. Muscle-derived cells were obtained from young male piglets and characterized. Upon expansion and fluorescent labeling, cells were injected into cadaveric tissue samples by either waterjet or injection needle. In other experiments, labeled cells were injected by waterjet in the urethra of living pigs and incubated for up to 7 days of follow-up. The analyses documented that the cells injected by waterjet in vitro were viable and proliferated well. Upon injection in live animals, cells appeared undamaged, showed defined cellular somata with distinct nuclei, and contained intact chromosomal DNA. Most importantly, by in vivo waterjet injections, a significantly wider cell distribution was observed when compared with needle injections (P < .05, n ≥ 12 samples). The success rates of waterjet cell application in living animals were significantly higher (≥95%, n = 24) when compared with needle injections, and the injection depth of cells in the urethra could be adapted to the need by adjusting waterjet pressures. We conclude that the novel waterjet technology injects viable muscle cells in tissues at distinct and predetermined depth depending on the injection pressure employed. After waterjet injection, loss of cells by full penetration or injury of the tissue targeted was reduced significantly in comparison with our previous studies employing needle injections.

Entities:  

Keywords:  cell therapy; muscle regeneration; myoblast injection; porcine model; urinary incontinence; waterjet technology

Mesh:

Year:  2022        PMID: 35466714      PMCID: PMC9036380          DOI: 10.1177/09636897221080943

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.139


  50 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

2.  Delivery of human mesenchymal adipose-derived stem cells restores multiple urological dysfunctions in a rat model mimicking radical prostatectomy damages through tissue-specific paracrine mechanisms.

Authors:  René Yiou; Meriem Mahrouf-Yorgov; Céline Trébeau; Marc Zanaty; Cécile Lecointe; Richard Souktani; Patricia Zadigue; Florence Figeac; Anne-Marie Rodriguez
Journal:  Stem Cells       Date:  2015-10-23       Impact factor: 6.277

3.  Autologous adipose stem cells in treatment of female stress urinary incontinence: results of a pilot study.

Authors:  Kirsi Kuismanen; Reetta Sartoneva; Suvi Haimi; Bettina Mannerström; Eija Tomás; Susanna Miettinen; Kari Nieminen
Journal:  Stem Cells Transl Med       Date:  2014-07-01       Impact factor: 6.940

4.  Rapid and precise delivery of cells in the urethral sphincter complex by a novel needle-free waterjet technology.

Authors:  Walter Linzenbold; Luise Jäger; Hartmut Stoll; Tanja Abruzzese; Niklas Harland; Nicolas Bézière; Andreas Fech; Markus Enderle; Bastian Amend; Arnulf Stenzl; Wilhelm K Aicher
Journal:  BJU Int       Date:  2020-10-23       Impact factor: 5.588

5.  Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction.

Authors:  Debra E Irwin; Zoe S Kopp; Barnabie Agatep; Ian Milsom; Paul Abrams
Journal:  BJU Int       Date:  2011-01-13       Impact factor: 5.588

6.  Quantitative analysis of survival of transplanted smooth muscle cells with real-time polymerase chain reaction.

Authors:  Tamotsu Yasuda; Richard D Weisel; Chris Kiani; Donald A G Mickle; Manjula Maganti; Ren-Ke Li
Journal:  J Thorac Cardiovasc Surg       Date:  2005-04       Impact factor: 5.209

7.  Developmental changes and the impact of isoflavones on mRNA expression of IGF-I receptor, EGF receptor and related growth factors in porcine skeletal muscle cell cultures.

Authors:  Claudia Kalbe; Marcus Mau; Charlotte Rehfeldt
Journal:  Growth Horm IGF Res       Date:  2008-10       Impact factor: 2.372

8.  Injection of Porcine Adipose Tissue-Derived Stromal Cells by a Novel Waterjet Technology.

Authors:  Marina Danalache; Jasmin Knoll; Walter Linzenbold; Markus Enderle; Tanja Abruzzese; Arnulf Stenzl; Wilhelm K Aicher
Journal:  Int J Mol Sci       Date:  2021-04-12       Impact factor: 5.923

Review 9.  The impact of urinary incontinence on self-efficacy and quality of life.

Authors:  Barbara Ann Shelton Broome
Journal:  Health Qual Life Outcomes       Date:  2003-08-22       Impact factor: 3.186

Review 10.  Integration of nano- and biotechnology for beta-cell and islet transplantation in type-1 diabetes treatment.

Authors:  Andras Dinnyes; Andrea Schnur; Suchitra Muenthaisong; Peter Bartenstein; Charles-Thibault Burcez; Neal Burton; Clemens Cyran; Pierre Gianello; Elisabeth Kemter; Gabor Nemeth; Francesco Nicotra; Eszter Prepost; Yi Qiu; Laura Russo; Andras Wirth; Eckhard Wolf; Sibylle Ziegler; Julianna Kobolak
Journal:  Cell Prolif       Date:  2020-04-27       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.